DermSpectra modernizes the way physicians can visually detect and monitor vital skin irregularities including moles, psoriasis, eczema, and lesions.

Dr. Mitchell Kline is a Clinical Assistant Professor at Weill Cornell Medical Center, and a highly regarded Clinical Dermatologist in New York City who specializes in melanoma diagnosis and clinical research.

"Until today, no one had solved the problem of objective, early skin cancer detection through standardized observation over time. Even the most thorough visual skin exams could miss critical skin changes. DermSpectra bridges an essential gap in our industry and will change the future of long term skin health for our patients," stated Dr. Kline.

Sancy Leachman, MD, PhD, Dermatology Department Chair and Director of the Melanoma Program at Oregon Health & Science University, is excited to bring this new technology to patients. "We see a high volume of melanoma patients and people who need careful monitoring of their skin," said Dr. Leachman.

"This is a step forward for our medical team to track and document skin changes and for patients to be empowered in their own skin care." OHSU provides expertise in the treatment of melanoma, high-risk basal cell carcinoma, squamous cell carcinoma, and various rare tumors.

DermSpectra’s patented system has an embedded stationary camera array, allowing total body imaging acquisition in less than 10 minutes. DermSpectra is the only product that combines whole body imaging, image standardization, post processing, and automation. It also features the highest resolution cameras on the market, including nine Nikon D810s, with 36.3 MP resolution cameras, which collect overlapping whole body images.

"DermSpectra is setting the industry standard with its innovative technology and imaging standardization," states Karleen Seybold, co-founder and CEO of DermSpectra. "We believe that every person should have a digital skin image in their electronic medical record, so skin changes can be precisely tracked over time for early detection of skin cancers and skin diseases."

DermSpectra Total Body Digital Skin Imaging provides primary care facilities, cancer centers, and dermatologists with an automated solution that can visually track vital skin irregularities, including moles, psoriasis, eczema, and lesions.

DermSpectra advanced medical technology changes the way physicians visually capture and compare skin changes by providing objective, ultra-high resolution images to aid in early detection of skin cancers.